These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28933418)

  • 1. Biomarkers in Lysosomal Storage Diseases.
    Bobillo Lobato J; Jiménez Hidalgo M; Jiménez Jiménez LM
    Diseases; 2016 Dec; 4(4):. PubMed ID: 28933418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in lysosomal storage diseases: a review.
    Cox TM
    Acta Paediatr Suppl; 2005 Mar; 94(447):39-42; discussion 37-8. PubMed ID: 15895710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current treatment options and novel nanotechnology-driven enzyme replacement strategies for lysosomal storage disorders.
    Del Grosso A; Parlanti G; Mezzena R; Cecchini M
    Adv Drug Deliv Rev; 2022 Sep; 188():114464. PubMed ID: 35878795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective.
    Thomas R; Kermode AR
    Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From bedside to cell biology: a century of history on lysosomal dysfunction.
    Coutinho MF; Matos L; Alves S
    Gene; 2015 Jan; 555(1):50-8. PubMed ID: 25275857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease.
    Aerts JM; van Breemen MJ; Bussink AP; Ghauharali K; Sprenger R; Boot RG; Groener JE; Hollak CE; Maas M; Smit S; Hoefsloot HC; Smilde AK; Vissers JP; de Jong S; Speijer D; de Koster CG
    Acta Paediatr; 2008 Apr; 97(457):7-14. PubMed ID: 18339181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies.
    Aerts JM; Kallemeijn WW; Wegdam W; Joao Ferraz M; van Breemen MJ; Dekker N; Kramer G; Poorthuis BJ; Groener JE; Cox-Brinkman J; Rombach SM; Hollak CE; Linthorst GE; Witte MD; Gold H; van der Marel GA; Overkleeft HS; Boot RG
    J Inherit Metab Dis; 2011 Jun; 34(3):605-19. PubMed ID: 21445610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of lysosomal storage diseases: recent patents and future strategies.
    Ortolano S; Viéitez I; Navarro C; Spuch C
    Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):9-25. PubMed ID: 24433521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme Replacement Therapy: A Review and Its Role in Treating Lysosomal Storage Diseases.
    Li M
    Pediatr Ann; 2018 May; 47(5):e191-e197. PubMed ID: 29750286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel biomarkers for lysosomal storage disorders: Metabolomic and proteomic approaches.
    Elmonem MA; Abdelazim AM
    Clin Chim Acta; 2020 Oct; 509():195-209. PubMed ID: 32561345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.
    Macauley SL
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1(Suppl 1):639-48. PubMed ID: 27491211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for Lysosomal Storage Disorders with an Emphasis on Mass Spectrometry.
    Mashima R; Okuyama T; Ohira M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A perspective on research, diagnosis, and management of lysosomal storage disorders in Colombia.
    Puentes-Tellez MA; Lerma-Barbosa PA; Garzón-Jaramillo RG; Suarez DA; Espejo-Mojica AJ; Guevara JM; Echeverri OY; Solano-Galarza D; Uribe-Ardila A; Alméciga-Díaz CJ
    Heliyon; 2020 Mar; 6(3):e03635. PubMed ID: 32258481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening.
    Kingma SD; Bodamer OA; Wijburg FA
    Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):145-57. PubMed ID: 25987169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Trials for Gene Therapy in Lysosomal Diseases With CNS Involvement.
    Sevin C; Deiva K
    Front Mol Biosci; 2021; 8():624988. PubMed ID: 34604300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn Screening for Lysosomal Storage Diseases: A Concise Review of the Literature on Screening Methods, Therapeutic Possibilities and Regional Programs.
    Schielen PCJI; Kemper EA; Gelb MH
    Int J Neonatal Screen; 2017 Jun; 3(2):. PubMed ID: 28730181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of gene therapy in canine and feline models of lysosomal storage disorders.
    Bradbury AM; Gurda BL; Casal ML; Ponder KP; Vite CH; Haskins ME
    Hum Gene Ther Clin Dev; 2015 Mar; 26(1):27-37. PubMed ID: 25671613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders.
    Coutinho MF; Santos JI; Alves S
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27384562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for lysosomal storage diseases: the lessons and promise of animal models.
    Ellinwood NM; Vite CH; Haskins ME
    J Gene Med; 2004 May; 6(5):481-506. PubMed ID: 15133760
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.